SMi Systems
Home Our Technology Biomedical Research Diagnosis Team Investors News Publications Careers Contact
HomeOur TechnologyBiomedical Research DiagnosisTeamInvestorsNewsPublicationsCareersContact
SMi Systems
SMi discusses how single molecule imaging could impact drug development

Single molecule analysis could transform drug development. Both the speed and quality of this process will be dramatically improved when there is a commercial single molecule platform that can accurately measure drug properties.


VIEW PDF
Lucy Eccleston10 June 2024Home News Block, 2024
Facebook0 Twitter 0 Likes
Previous

SMi drives commercialisation and growth by appointing Stefan Hamill as VP of Strategy

Lucy Eccleston9 July 20242024
Next

SMi moves closer to ISO 13485 certification

Lucy Eccleston22 May 20242024
 

About Us
About SMi
Meet the Team
Careers
Investors
Publications
News
Contact Us

Technology & Sectors
Our Technology
Biomedical Research
Diagnosis

 

Policies & Information
Privacy Policy
Terms of Use
Company Information
Recruitment Privacy Policy

SMi Drug Discovery
Company Registration No.: 11175710
VAT No.: 332498687
Trading as SMi Systems

© 2024 SMi Drug Discovery Limited